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Abstract
Introduction The beta-adrenoceptor antagonist propranolol is
known to reduce peripheral and central activity of noradrena-
line. A recent study found that intervention with propranolol
diminished negative implicit racial bias.
Materials and method The current study used functional mag-
netic resonance imaging (fMRI) in order to determine the
neural correlates of this effect. Healthy volunteers (N=40) of
white ethnic origin received a single oral dose (40 mg) of
propranolol, in a randomised, double-blind, parallel group,
placebo-controlled design, before viewing unfamiliar faces
of same and other race.
Results and discussion We found significantly reduced activ-
ity in the fusiform gyrus and thalamus following propranolol
to out-group faces only. Additionally, propranolol lowered the
implicit attitude score, without affecting explicit prejudice
measure.
Conclusion These findings suggest that noradrenaline path-
ways might modulate racial bias by acting on the processing
of categorisation in the fusiform gyrus.
Keywords Emotion . fMRI
Introduction
Over the past decade, important advances have been
made in understanding the neuropsychological mecha-
nisms underlying racial biases. Research has suggested
that social attitudes might have distinct components. In
particular, this research has distinguished between an
explicit component, an automatic/ implicit component
and a behavioural component (Nosek et al. 2011). It
has been further suggested that explicit aspects of inter-
group attitudes are primarily cognitive, whereas implicit
biases might have a stronger emotional component
(Nosek et al. 2011). The role of emotion in implicit
in-group bias has been demonstrated by recent research,
which has also implicated key brain regions, such as the
amygdala, the dorsolateral prefrontal cortex and the fu-
siform gyrus, in such implicit responses (Cunningham
et al. 2004; Phelps et al. 2000; Stanley et al. 2008).
In line with this work, we recently found that a single dose
of the β-adrenoceptor antagonist propranolol significantly re-
duced implicit racial bias as measured by the Implicit
Association Test (IAT), but had no effect on explicit prejudice
(Terbeck et al. 2012). This result suggests that noradrenergic-
mediated arousal, which is sensitive to propranolol, may play
a causal role in some forms of implicit racial bias. The reduc-
tion may have been associated with a modulation of central
noradrenergic transmission in limbic and other brain areas,
previously found to be activated by presentation of out-
group faces. These areas include a network of limbic and
cortical regions, including the amygdala, insula, fusiform gy-
rus, anterior cingulate cortex, and dorsolateral prefrontal cor-
tex (Cunningham et al. 2004; Knutson et al. 2007; Phelps et al.
2000; Richeson et al. 2003; Stanley et al. 2008). For instance,
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previous studies have found differential activation to in- ver-
sus out-group faces in the amygdala (Phelps et al. 2000), the
prefrontal cortex (Cunningham et al. 2004; Knutson et al.
2007; Richeson et al. 2003; Stanley et al. 2008), as well as
the fusiform gyrus (Brosch et al. 2012; Contreras et al. 2013;
Golby et al. 2001; Natu et al. 2011). These brain regions also
show high density of noradrenaline receptors (Chamberlain
et al. 2006), and previous studies found that a reduction in
noradrenergic transmission, via propranolol, also led to re-
duced activity in such limbic regions when participants
viewed emotional pictures during the functional magnetic res-
onance imaging (fMRI) scan (Hurlemann et al. 2010). In ad-
dition, previous psychological research has suggested that im-
plicit racial bias might be mediated by affective fear responses
(Nosek et al. 2011), supporting the hypothesis that the reduc-
tion of negative bias after propranolol (Terbeck et al. 2012)
might be correlated with differential limbic brain activation
patterns, which underly such arousal responses. Thus, the
aim of the present study was to investigate the effect of pro-
pranolol on neural responses to racial out- versus in-group
faces. We predicted that propranolol would decrease activa-
tion in the limbic network to black (out-group) versus white
faces (in-group), and that, behaviourally, the IAT score would
be also be decreased.
Method
Participants and design
Forty right-handed healthy individuals (Mage=21.93 years; 24
male, 16 female, all white) participated in this research after
written informed consent was obtained. Participants were re-
cruited via poster and email advertisements and were initially
medically and psychologically screened, including measure-
ment of blood pressure and the recording of an ECG.
Participants with any contra-indications to propranolol admin-
istration, as well as any history of mental illness (as assessed
by the Structural Clinical Interview for DSM-Clinical Version,
SCID-IV, First and Gibbon 1997; Beck’s Depression
Inventory, Beck et al. 1961; and Eysenck’s Neuroticism and
Psychoticism scale, Eysenck, Eysenck et al. 1985), were ex-
cluded from the study. The study was approved by an NHS
research ethics committee.
The study used a double-blind, placebo-controlled, par-
allel group design where participants were randomly allo-
cated to receive either placebo or propranolol (40 mg)
orally, 1 h before fMRI, to achieve a peak plasma concen-
tration of propranolol (Gilman et al. 1980) during the
scan. The fMRI scan lasted 30 min, and tests of implicit
racial associations and explicit prejudice were then com-
pleted outside the scanner. Heart rate was measured every
30 min using a pulse oximeter. Due to a technical failure,
all data for one participant in the placebo group were not
being recorded.
fMRI task
The design of the fMRI task was based on Phelps et al. (2000);
we chose this block design task, since it was also used in the
original investigation of IAT effect and racial face perception,
and made it thus most comparable to the original paradigm.
Additionally, we previously also found robust arousal re-
sponses to emotional stimuli using a block design (Murphy
et al. 2009). Participants viewed unfamiliar black and white
male faces in the scanner. The faces were taken from the
Stanford University faces database (https://stanforduniversity.
qualtrics.com/SE/?SID=SV_aX0ovSkASZR9Py4). These
faces were previously rated by over 100 participants in an
online web study on the dimensions of attractiveness,
stereotypicality, and age. Attractiveness and stereotypicality
dimensions were rated using a 7-point scale, while the age
dimension used a 10-point scale. We selected a group of 36
black and 36 white faces that did not significantly differ on
the ratings of attractiveness, stereotypicality, and age. In this
task, nine 18-s blocks of a baseline fixation cross (condition
A) were interleaved with eight 18-s blocks consisting of four
blocks of white faces (condition B) and four blocks of black
faces (condition C). During each task, block participants
viewed nine faces, each presented for 1500ms, and participants
were asked to judge the age of the person in the picture (‘Is the
person older than 25 years?’, 0=No or 1=Yes). The age rating
task was analogous to the procedure used byWheeler and Fiske
(2005). Stimuli were presented using E-Prime (Version 1.0) and
a cloned projection displayed to participants on an opaque
screen located at the head of the scanner bore, which partici-
pants viewed using angled mirrors. Participants responded via
an MRI-compatible keypad. Stimulus presentation/participant
button presses were registered and time-locked to fMRI data
using E-Prime. Both response (judgement of age) and reaction
times were recorded for 1000 ms and 500-ms inter-stimulus
intervals. Four blocks of resting—staring at the central fixation
cross—were interleaved and lasted for 18,000 ms each. Faces
were presented in random order. Participants responded using a
left and right response button. Response time and responses
(using the MRI-compatible keypad) were recorded via E-
prime software.
fMRI data acquisition
All imaging data were obtained using a 3T Siemens Tim Trio
system. Functional imaging consisted of T2*-weighted echo-
planar image (EPI) slices [repetition time (TR)=2000ms, ech-
o time (TE)=28 ms, matrix=192×192], with 3.5-mm slice
thickness. The first two EPI volumes in each session were
discarded to avoid T1 equilibration effects.
2952 Psychopharmacology (2015) 232:2951–2958
fMRI data analysis
Functional MRI data were pre-processed and analysed using
FSL software (Version 4.8, www.fmrib.ox.ac.uk/fsl). Pre-
processing included slice acquisition time correction (using
Fourier-space time-series phase shifting), within-subject im-
age realignment, non-brain removal spatial normalisation to a
standard template (Montreal Neurological Institute, MNI, 152
stereotactic template), using an affine procedure and spatial
smoothing using a Gaussian kernel (5 mm full width at half
maximum). The time series in each session was high-pass
filtered (to a maximum of 0.0125 Hz). Analyses of data from
individual participants were computed using the general linear
model approach with local autocorrelation correction. For the
faces task, the explanatory variables were modelled: ‘black
face’, ‘white face’ and ‘fixation’. In addition, temporal deriv-
atives were included in the model as covariates of no interest
to increase statistical sensitivity. All variables were modelled
by convolving each block with a haemodynamic response
function, using a variant of a gamma function (that is, a nor-
malisation of the probability density function of the gamma
function) with a standard deviation of 3 s and a mean lag of
6 s. At the group level, data were analysed using a mixed
effects analysis. In a whole brain analysis, significant activa-
tions were identified using cluster-based thresholding of sta-
tistical images with a height threshold of Z=2.5 and a
(corrected) spatial extent threshold of p<0.05. In addition to
our whole brain analysis, we also examined limbic network
structures as a priori regions of interest.
Implicit association test
The IAT (Greenwald et al. 1998) was presented using E-Prime
(Version 2.0) software. This test consists of congruent and
incongruent blocks. In the congruent trials participants have
to categorize positive words with white faces and negative
words with black faces. In the incongruent trials, participants
have to categorise positive words with black faces and nega-
tive words with white faces. There were 60 congruent and 60
incongruent trials (20 of each were classified as practice tri-
als). The implicit association bias is revealed by computing
the difference in response times for congruent and incongruent
blocks (i.e. if response times for incongruent conditions are
greater than for congruent ones, a positive IAT score is pro-
duced, indicating that the participant had a more accessible
association of positive/white face and negative/black face
categorisations than for negative/white face and positive/
black face associations). The IAT score is represented as a
D-measure (See Greenwald et al. 2003). Specifically, a high
value indicates strong greater association of black with bad
and white with good (higher implicit bias). Faces as well as
words and design of the task were analogous to the original
version developed by Greenwald et al. (1998). The faces for
the IAT task were not the same faces as used in the fMRI task.
Explicit measure
Explicit racial attitudes were measured using two different
methods:
(a) A feeling thermometer (Converse and Presser 1986)
was used, an established method to test self-reported
out-group attitudes. This is a 10-item scale in which
participants express how cold or warm they feel to-
wards a target group (10=cold, to 100=warm). The
difference between the items ‘feeling for in-group’
and ‘feeling for out-group’ was calculated. A positive
score indicated greater negative/cold feeling towards
the out-group.
(b) In a second explicit measure, participants rated their feel-
ings towards in- and out-groups on six 8-point semantic-
differential items [for placebo group (alpha)=.87; for
propranolol group (alpha)=.92): 1, 0=cold, 7=warm;
2, 0=positive, 7=negative; 3, 0=hostile, 7=friendly; 4,
0=trusting, 7=suspicious; 5, 0=contempt, 7=respect; 6,
0=disgust, 7=admiration (7)]. The items were coded so
that a higher score indicated a more negative out-group
evaluation; items 2 and 4 were reverse coded. This meth-
od for assessing explicit prejudice towards other groups
was based on previous research, for example by Wright
et al. (1997).
Self-reported mood: visual analogue scales
Self-reported mood was assessed using visual analogue
scales. Participants indicated on 20-cm lines the degree to
which they felt tense, sad, angry, tired, happy or alert. We
subsequently measured (in cm) where participants made their
cross on the line (0.00–20.00). The higher the score, the great-
er the indicated level of assessed mood. This measure was
obtained at three time points: at baseline (i.e. before the inter-
vention), 1 h after drug/placebo administration, whichwas just
before the scan, and at the end of the experiment (i.e. 150 min
after intervention).
Results
Both groups were well matched across all demographics mea-
sured, including depression and personality scores (i.e. there
were no significant differences on independent sample t tests
for all demographic variables; all ps<.05) (see Table 1).
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Heart rate analysis
We computed a 2 (intervention: placebo versus proprano-
lol)×6 (time) mixed model analysis of variance (ANOVA)
with repeated measures on the latter factor. The data from
one participant was missing, as the pulse oximeter did not
record the data in the fMRI scanner. A significant interven-
tion×time interaction was found [F(5,32)=2.96, p<.03;
η2=.32]. Heart rate was significantly reduced in the propran-
olol group 60 min after treatment and remained lower for all
further 30-min measurement points [at 0 min: propranolol
(PR), M=68.57, SD=10.21; placebo (PL), M=72.71, SD:
9.77; t(36)=1.27, p=.21; at 30 min: PR, M=64.67, SD=
9.41; PL, M=70.65, SD=9.94; t(36)=1.90, p= .07; at
60 min: PR, M=59.81, SD=9.00; PL, M=70.82, SD=10.38;
t(36)=3.51, p<.01; at 90 min: PR, M=55.05, SD=8.78; PL,
M=67.94, SD=9.31; t(36)=4.38, p<.00; at 120 min: PR,M=
55.90, SD=8.71; PL: M=69.28, SD=10.39; t(36)=4.32,
p<.00; at 150 min: PR, M=56.95, SD=7.75; PL, M=68.76,
SD=7.63; t(36)=4.71, p<.00).
Self-reported mood
There were no group differences in self-reported mood at any
of the three measurement times (all ps>.2).
Implicit association test
The IAT was analysed according to the Greenwald et al.
(2003) improved algorithm. In the analysis, all trials were
considered. Following the procedures of the improved algo-
rithm, errors were replaced with the mean for correct trials in
that block+600 ms. The resulting values were divided by their
pooled standard deviation for correct trials (for a full descrip-
tion of the method, see Greenwald et al. 2003). Three partic-
ipants had excessive error rates as well as more than three
consecutive errors in the main blocks and were thus excluded.
In addition, the practice trials of two participants were not
included in the main analysis as they were excessively slow
in responding (i.e. response times over 4000 ms) during the
practice session. The corrected difference between congruent
and incongruent trials revealed the standardised IAT effect.
The IAT was lower in the propranolol group (M=.46,
SD=.37) compared to the placebo group (M=.81, SD=.75).
This difference was significant, one tailed [t(35)=1.83, p=
0.04, d=.62] (see Fig. 1).
Explicit measures
We conducted a t test to determine group differences in self-
reported feelings towards in- and out-groups on the semantic
differential measure based on Wright et al. (1997). There were
no significant differences in explicit prejudice between pro-
pranolol and placebo conditions (Mplacebo=31.50, SD=6.00;
Mpropranolol=29.24, SD=6.35; t(37)=1.14, p=.26). For the feel-
ing thermometer (which was non-normally distributed), we
conducted a Mann–Whitney U test to determine group differ-
ences; again, there were no significant differences in explicit
racial prejudice (Mrankplacebo=20.78; Mrankpropranolol=19.33;
p>.2).
fMRI task and neural responses
In order to determine differences in behavioural responses to
the age task (i.e. differences in response and/or response time
to black/white faces) following propranolol intervention, we
conducted a 2 (intervention: propranolol versus placebo)×2
(race: black face versus white face) mixed ANOVA, with re-
peated measures on the last factor. We found no interaction
effect with intervention (p>.05).
Whole brain analyses revealed greater activation under pla-
cebo versus propranolol for black versus white faces in the
fusiform gyrus, including the fusiform face area, and the
Table 1 Demographic data for placebo and propranolol group
Variable Mean SD p value
Gender PL=11 female
PR=11 female
Age PL=21.94 PL=2.84 n.s.
PR=21.38 PR=2.97
Depression inventory PL=1.39 PL=1.69 n.s.
PR=.95 PR=1.40
Neuroticism scale PL=1.56 PL=1.58 n.s.
PR=1.90 PR=2.02
PL placebo, PR propranolol
Fig. 1 IAT score in placebo and propranolol groups. Scores are
normalised by division through the pooled standard deviation for
correct trials, as stated in the improved algorithm analysis
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thalamus. Additionally, using an region of interest (ROI) ap-
proach generated from the Harvard-Oxford anatomical atlas
we observed greater activation under placebo to black versus
white faces in the fusiform gyrus bilaterally (Table 2 and
Fig. 2). There were no regions that showed greater activation
to black versus white faces in the propranolol group as com-
pared to placebo. In addition, for no participant was there
greater activation when comparing white versus black faces.
ROI analysis in the amygdala confirmed no differential acti-
vation of black versus white faces. Importantly, decomposing
the significant fusiform gyrus interaction, we found reduced
activity to black faces versus baseline as the only effect and
only for the propranolol group (Fig. 3).
Additionally, following Natu et al. (2011), we further in-
vestigated the time course of activity in the fusiform gyrus
during the block. Therefore, nine time points (early–late) were
calculated as means for all blocks. The activity was then nor-
malised, and activity for black and white faces was subtracted
from baseline activity. Figure 4 shows the time course of fu-
siform activity for black and white faces within propranolol
and placebo group. As depicted in Fig. 4, for placebo as well
as propranolol conditions, activity in response to white faces
was highest at initial presentation and then declined. For black
faces, however, participants in the placebo group showed an
opposite pattern where fusiform gyrus activity increased over
time. The latter effect was less pronounced following
propranolol.
Discussion
We found that propranolol reduced neural activation to black
versus white faces in the fusiform gyrus and thalamus.
Propranolol lowered IAT scores, which was significant on a
one-tailed test, in line with the same finding we reported in
Terbeck et al. (2012), while the measure of explicit prejudice
was not affected (again replicating Terbeck et al. 2012). These
results extend previous work implicating the fusiform gyrus as
part of a network of regions subserving out-group perception,
and support the proposal that it is a key region involved in the
racial categorisation of viewed faces.
The amygdala has long been regarded as a possible neural
substrate of implicit racial bias (Wheeler and Fiske 2005). For
example, in an early study, Phelps et al. (2000) found a positive
correlation between the IAT score and the extent of amygdala
activation when white participants viewed unfamiliar black
and white faces. Subsequent fMRI studies have generally
found greater amygdala responses to black compared to white
faces (Cunningham et al. 2004; Wheeler and Fiske 2005).
However, in our study, we found no effect in the amygdala
indicating greater activation to black and white faces.
Methodological differences may help to explain these
apparently inconsistent results. For example, Cunningham
et al. (2004) showed that the differential amygdala response
to black compared to white faces was dependent on the dura-
tion of stimulus presentation, with short presentation times
(30 ms) producing a substantially greater effect than longer
presentations (525 ms). Our own presentation time was
1500 ms; however, Wheeler and Fiske (2005) reported a sig-
nificant differential amygdala response to black and white
faces in a similar paradigm to our own with a presentation
time of 2 s. Hence, demonstration of a greater amygdala re-
sponse to black versus white faces may depend importantly on
experimental parameters such as the nature of the presentation
of the visual stimulus and the number of repetitions, as well as
the experiences of the participants. Indeed, a recent review of
neuroimaging studies and racial prejudice suggests that amyg-
dala activity might not reflect a racial out-group bias per se
(Chekroud et al. 2014).
While the amygdala plays an important role in the emo-
tional modulation of the processing of faces, the fusiform gy-
rus has been strongly linked to the determination of the iden-
tity of faces. We did not identify the fusiform gyrus as an a
priori ROI for our study. However, bilateral fusiform effects
were identified by the whole brain analysis, which supports
the post hoc analysis. In addition, there is strong evidence
Table 2 Regions of increased activation under placebo versus propranolol for the orthogonal contrast black versus white faces
Brain region Cluster size (voxels) Z score p value x y z
Thalamus 3871 4.33 <.001 −18 −30 6
Fusiform gyrus 590 3.57 0.03 −28 −66 −16
Coordinates refer to the position (x, y and zmm) for the peak voxel in each cluster according to the MNI template
Fig. 2 Whole brain image under placebo versus propranolol to black
versus white faces. Whole brain image depicting greater activation
under placebo versus propranolol to black versus white faces. Image
thresholded at Z=2.3, p>0.05, corrected. Images are in radiological
format (right brain on left)
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from other studies that the fusiform gyrus, particularly the
fusiform face area (FFA), plays a key role in the representation
of racial identity (Brosch et al. 2012; Contreras et al. 2013;
Golby et al. 2001; Natu et al. 2011).
A study by Contreras et al. (2013) used multivoxel
pattern analysis to decode activity in the FFA while par-
ticipants viewed images of faces of different races and
genders. They found that the FFA distinguished both gen-
der and race of individual faces. However, patterns ex-
tracted from other face-selective cortical regions involved
in early visual processing did not identify either gender or
race, suggesting these categorisations might be confined
to the FFA.
Relevant to our study, the ability of the FFA to repre-
sent race appears to be modified by racial bias as mea-
sured by the IAT. For example, Brosch et al. (2013), using
a similar multivoxel pattern approach to that of Contreras
et al. (2013), found that successful decoding of racial
identification in the FFA was only possible in participants
with high levels of implicit racial bias. However, and in
contrast to Contreras et al. (2013), these authors also
found that racial identity could be successfully decoded
on the basis of activation patterns in early visual process-
ing areas. They concluded that, while the latter regions
distinguished race by identifying basic perceptual fea-
tures, the FFA was involved in higher order facial identi-
fication such as social categorisation.
In our study, propranolol lowered implicit bias and
significantly diminished the activation elicited by viewing of
black faces in the fusiform area but did not alter the activation
to white faces. Natu et al. (2011) presented evidence showing
that the processing of black and white faces in white partici-
pants has a differential time course in the fusiform area with
‘same race’ faces producing a large early activation, while
‘other race’ faces produce a more delayed response that even-
tually equals or even exceeds that occurring in response to
‘same race’ faces. Our findings regarding the time course of
fusiform gyrus activity support this notion; in both groups,
activity in response to white faces was high initially and then
declined. In the placebo condition, however, fusiform gyrus
activity for black faces increased over time, suggesting that
propranolol selectively reduced the differential processing of
out-group faces in the fusiform area. Therefore, propranolol
may interfere with the ‘other race’ distinction that seems to be
an important property of fusiform processing during the rec-
ognition of racial identity.
If the fusiform area is a key region for recognising the
identity of out-group faces, it may also play an important role
in generating implicit racial bias. While the amygdala is a
candidate region for this effect, a study by Phelps et al.
(2003) indicated that implicit bias measured by the IAT was
still present in a participant with bilateral amygdala damage,
suggesting that the amygdala itself may not play a critical role
in the manifestation of implicit bias. The site of action of
propranolol to influence fusiform activity when viewing black
faces is not clear from the present study, also since we did not
find an overall correlation of IAT score and fusiform gyrus
activity. Propranolol is known to influence the amygdala re-
sponse to negative emotional faces but, as noted above, the
current study does not suggest an effect mediated via the
amygdala. However, Norbury et al. (2007) found that short-
term intervention with the noradrenaline re-uptake inhibitor
reboxetine increased responses in the fusiform gyrus to happy
faces, suggesting that noradrenaline can modulate responses
to emotional faces in this area and supporting the view that the
fusiform plays a role in different kinds of complex social
categorisation (Bosch et al. 2013). Future research might in-
vestigate which specific aspect of racial face perception (e.g.
configural or featural processing) might be affected.
We also found reduced activation to black versus white
faces in the thalamus; this effect was not predicted but was
apparent at the level of whole brain analysis. The thalamus has
also been implicated in face perception (Phelps and LeDoux
2005; Vuilleumier and Pourtois 2007); thus, a direct pathway
from thalamus to amygdala facilitates the rapid detection of
emotionally salient stimuli, and projections from amygdala to
the fusiform gyrus have been implicated in the increased ac-
tivity in the fusiform face area in response to emotional faces
(Phelps and LeDoux 2005; Vuilleumier and Pourtois 2007).
The thalamus itself is known to be activated by demanding
visual tasks involving selective attention and visual discrimi-
nation (Sabatinelli et al. 2011), and there are reciprocal con-
nections between thalamus and fusiform face area (Clarke
et al. 1999). This may well be relevant to our findings of a
similar attenuation by propranolol to out-group faces in the
thalamus as in the fusiform face area.
Fig. 3 Decomposed interaction in the fusiform gyrus. Mean fusiform
gyrus activity in placebo and propranolol group for black faces baseline
and white faces baseline
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In our previous behavioural study, we found that pro-
pranolol significantly lowered racial bias as measured by
the IAT. Our findings with respect to the effect of pro-
pranolol on the IAT in the present study, while similar in
nature, were less robust (significant at a one-tailed level
only). However, this might be accounted for by the par-
ticular experimental conditions, namely that the IAT was
carried out after the task in the scanner, which involved
repeated viewing of black versus white faces. Future re-
search might test this proposal. Moreover, plasma levels
of propranolol would likely have been declining when the
participants completed the IAT. Furthermore, we used a
between-group design, as it would be very difficult to
have participants performing the same tasks (e.g. IAT
Fig. 4 Time course of fusiform
gyrus activity for black and white
faces in placebo and propranolol
group
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and fMRI) twice without affecting the reliability of the
results.
In summary, we found reduced activation in both fusiform
gyrus and thalamus in participants who received propranolol
and who viewed unfamiliar black versus white faces. In addi-
tion, the IAT score was lower in participants receiving propran-
olol. These results support the conjecture that implicit aspects of
racial attitudes have an underlying neural component in which
face processing in the fusiform gyrus plays an important role. It
should be noted, however, the we did not use a functional face
localiser to delineate the FFA, which is a weakness of the study.
Future work could also link current work on multivoxel pattern
analysis in the FFAwith the effects of pharmacological manip-
ulation of implicit bias (Terbeck et al. 2012; Contreras et al.
2013). For example, it would be of great interest to determine
if propranolol was able to impair the decoding of the FFA
activation patterns that represent different racial faces. This
could provide a plausible neurobiological substrate for the abil-
ity of propranolol to diminish implicit racial bias.
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